Femasys Inc. has announced a regulatory issue concerning its listing on The Nasdaq Stock Market. On July 16, 2025, the company received a notice of noncompliance with Nasdaq's Listing Rule 5550(a)(2), as its common stock's minimum bid price has been below $1.00 per share for 30 consecutive business days. This notification, however, does not immediately affect the stock's current listing or trading status. Femasys has until January 12, 2026, to meet the Minimum Bid Price Requirement, which entails maintaining a bid price of at least $1.00 per share for ten consecutive business days. The company is considering options to regain compliance, such as a reverse stock split, although there is no assurance of success. If compliance is not achieved, Femasys may face delisting, but it may also seek a second compliance period if it meets other initial listing standards.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.